206 related articles for article (PubMed ID: 5726968)
1. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
Agati G
Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
[No Abstract] [Full Text] [Related]
2. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
Massenti S; Perri G
Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
[No Abstract] [Full Text] [Related]
3. [Fractionation protocols in radiotherapy].
Navarrete S; Marín Górriz FJ; Hernández Vitoria A; Bellosta Ferrer R; López Marín P; Castillo Ramírez A
Rev Esp Oncol; 1984; 31(3):515-27. PubMed ID: 6546179
[TBL] [Abstract][Full Text] [Related]
4. Sensitizers in radiotherapy.
Dische S
Br J Hosp Med; 1982 May; 27(5):502, 507-10. PubMed ID: 7093576
[No Abstract] [Full Text] [Related]
5. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
Kummer H; Bucher U
Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643
[No Abstract] [Full Text] [Related]
6. [Current status of anticancer chemotherapy. Progress in concept, methods and means].
Chauvergne J
Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):271-89. PubMed ID: 897407
[No Abstract] [Full Text] [Related]
7. Radiosensitizing action of ametohepazon on the irradiated tumor tissues. II. Preliminary clinical report.
Niibe H; Tobe T; Kato T; Hirai E; Toda N
Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):995-1006. PubMed ID: 5245253
[No Abstract] [Full Text] [Related]
8. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
9. Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents.
Milas L; Tofilon PJ; Brock WA
Prog Clin Biol Res; 1986; 212():305-21. PubMed ID: 3520579
[No Abstract] [Full Text] [Related]
10. Modification of radiotherapy by radiosensitizers and cancer chemotherapeutic agents. II. Cancer chemotherapeutic agents.
Looney WB; Hopkins HA
Semin Oncol; 1989 Jun; 16(3):176-9. PubMed ID: 2658081
[No Abstract] [Full Text] [Related]
11. [Problems in the combined therapy of radiation and chemotherapeutic agents].
Morita K
Rinsho Hoshasen; 1974 May; 19(5):329-37. PubMed ID: 4607678
[No Abstract] [Full Text] [Related]
12. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Coleman CN
Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
[No Abstract] [Full Text] [Related]
13. [Recent acquisitions in cancer chemotherapy].
Amiel JL; Bernard J; Bessis M; Dreyfus B; Najean Y; Seligmann M; Péquignot H
Presse Med (1893); 1966 Jun; 74(32):1683-6. PubMed ID: 5935822
[No Abstract] [Full Text] [Related]
14. Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
Milas L; Gregoire V; Hunter N; Kurdoglu B; Mason K; Meyn R
Adv Exp Med Biol; 1997; 400B():559-64. PubMed ID: 9547604
[No Abstract] [Full Text] [Related]
15. [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].
Hansen MM; Hertz H
Ugeskr Laeger; 1966 Mar; 128(11):313-6. PubMed ID: 5331165
[No Abstract] [Full Text] [Related]
16. [Clinical experiences with a methylhydrazine derivative (Natulan)].
Hertz H; Hansen MM; Videbaek AA
Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
[No Abstract] [Full Text] [Related]
17. [Segidrin: a new-type antineoplastic agent].
Filov VA
Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
[No Abstract] [Full Text] [Related]
18. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of hematoporphyrin derivative in malignant tumors.
Ha XW; Sun XM; Xie JG; Fan XJ; Zhang YH; Mei QC; Shen H; Xu SL; Zhang RG
Chin Med J (Engl); 1983 Oct; 96(10):754-8. PubMed ID: 6233105
[No Abstract] [Full Text] [Related]
20. [General principles and new trends of cytostatic tumor therapy].
Holfeld H; Bamberg M
Strahlentherapie; 1980 May; 156(5):297-307. PubMed ID: 7190333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
